featured
Nab-Paclitaxel vs Paclitaxel in Patients With Platinum-Refractory Metastatic Urothelial Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and Safety of Nab-Paclitaxel vs Paclitaxel on Survival in Patients With Platinum-Refractory Metastatic Urothelial Cancer: The Canadian Cancer Trials Group BL.12 Randomized Clinical Trial
JAMA Oncol 2020 Sep 17;[EPub Ahead of Print], SS Sridhar, N Blais, B Tran, MN Reaume, SA North, MR Stockler, KN Chi, NE Fleshner, G Liu, JW Robinson, SD Mukherjee, Y Rahim, E Winquist, CM Booth, NT Nguyen, EK Beardsley, NS Alimohamed, GT McDonald, K Ding, WR ParulekarFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.